Mather Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
Mather Group's INSM Position: Q3 2026 in Review
Mather Group increased its Insmed (INSM) stake by 359% in Q3 2026, buying an estimated $9.31K and bringing the position to 101 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.
Mather Group first reported a position in INSM in Q1 2024 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- Mather Group held 101 shares of Insmed worth $11.5K as of Q3 2026.
- Mather Group bought 79 Insmed shares in Q3 2026, an estimated $9.31K.
- Insmed made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1604 holding.
- Mather Group first reported a position in Insmed in Q1 2024 and has held it in 6 quarters since.
- 114 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.